Cargando…

Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study

BACKGROUND: Palliative care has improved the quality of end-of-life (EOL) care and lowered the health care cost of cancer, and these benefits should be extended to patients with other serious illnesses including end-stage kidney disease. We evaluated the quality of EOL care, survival probabilities,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Jui-Kun, Chen, Jean-Shi, Kao, Yee-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636130/
https://www.ncbi.nlm.nih.gov/pubmed/31311518
http://dx.doi.org/10.1186/s12882-019-1440-9
_version_ 1783436010661609472
author Chiang, Jui-Kun
Chen, Jean-Shi
Kao, Yee-Hsin
author_facet Chiang, Jui-Kun
Chen, Jean-Shi
Kao, Yee-Hsin
author_sort Chiang, Jui-Kun
collection PubMed
description BACKGROUND: Palliative care has improved the quality of end-of-life (EOL) care and lowered the health care cost of cancer, and these benefits should be extended to patients with other serious illnesses including end-stage kidney disease. We evaluated the quality of EOL care, survival probabilities, and health care costs for dialysis patients in their last month of life. METHODS: We conducted a population-based study and analyzed data from Taiwan’s Longitudinal Health Insurance Database, which contains claims information of patient medical records, health care costs, and insurance system exit dates (our proxy for death between 2006 and 2011). RESULTS: Data of 1177 adult patients who died of chronic hemodialysis or peritoneal dialysis were investigated. The mean age of these patients was 69.7 ± 11.9 years, and 585 (49.7%) were women. Some patients with dialysis received cardiopulmonary resuscitation (66.9%), died in a hospital (65.0%), or were admitted to an intensive care unit (51.0%) in the last month of life. We further classified these patients into two groups, namely dialysis with cancer (DC) (n = 149) and dialysis without cancer (D) (n = 1028). Only 19 dialysis patients received palliative care, and the proportion of patients receiving palliative care was higher in the DC group than in the D group (11.4% vs. 0.2%). The mean health care costs per person during the final month of life was similar between the DC and D groups (USD 2755 ± 259 vs. USD 2827 ± 88). Multivariate logistic regression showed that the DC group had lower odds of receiving cardiopulmonary resuscitation (CPR) (OR: 0.39, CI = 0.26–0.56, p < 0.001) procedures, higher odds of longer hospital stays than the third quartile (> 25 days) (OR: 1.52, CI = 1.01–2.29, p = 0.0046), and higher odds of being hospitalized more than once (OR: 2.26, CI = 1.42–3.59, p = 0.001) than the D group in the last month of life after adjustments. CONCLUSIONS: DC patients received hospice care more frequently, received CPR less frequently, and had similar health care costs. DC patients also had a higher risk of a hospital stay that lasted more than 25 days and more than one hospitalization compared with D patients in the final month of life. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-019-1440-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6636130
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66361302019-07-25 Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study Chiang, Jui-Kun Chen, Jean-Shi Kao, Yee-Hsin BMC Nephrol Research Article BACKGROUND: Palliative care has improved the quality of end-of-life (EOL) care and lowered the health care cost of cancer, and these benefits should be extended to patients with other serious illnesses including end-stage kidney disease. We evaluated the quality of EOL care, survival probabilities, and health care costs for dialysis patients in their last month of life. METHODS: We conducted a population-based study and analyzed data from Taiwan’s Longitudinal Health Insurance Database, which contains claims information of patient medical records, health care costs, and insurance system exit dates (our proxy for death between 2006 and 2011). RESULTS: Data of 1177 adult patients who died of chronic hemodialysis or peritoneal dialysis were investigated. The mean age of these patients was 69.7 ± 11.9 years, and 585 (49.7%) were women. Some patients with dialysis received cardiopulmonary resuscitation (66.9%), died in a hospital (65.0%), or were admitted to an intensive care unit (51.0%) in the last month of life. We further classified these patients into two groups, namely dialysis with cancer (DC) (n = 149) and dialysis without cancer (D) (n = 1028). Only 19 dialysis patients received palliative care, and the proportion of patients receiving palliative care was higher in the DC group than in the D group (11.4% vs. 0.2%). The mean health care costs per person during the final month of life was similar between the DC and D groups (USD 2755 ± 259 vs. USD 2827 ± 88). Multivariate logistic regression showed that the DC group had lower odds of receiving cardiopulmonary resuscitation (CPR) (OR: 0.39, CI = 0.26–0.56, p < 0.001) procedures, higher odds of longer hospital stays than the third quartile (> 25 days) (OR: 1.52, CI = 1.01–2.29, p = 0.0046), and higher odds of being hospitalized more than once (OR: 2.26, CI = 1.42–3.59, p = 0.001) than the D group in the last month of life after adjustments. CONCLUSIONS: DC patients received hospice care more frequently, received CPR less frequently, and had similar health care costs. DC patients also had a higher risk of a hospital stay that lasted more than 25 days and more than one hospitalization compared with D patients in the final month of life. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-019-1440-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-16 /pmc/articles/PMC6636130/ /pubmed/31311518 http://dx.doi.org/10.1186/s12882-019-1440-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chiang, Jui-Kun
Chen, Jean-Shi
Kao, Yee-Hsin
Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
title Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
title_full Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
title_fullStr Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
title_full_unstemmed Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
title_short Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
title_sort comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636130/
https://www.ncbi.nlm.nih.gov/pubmed/31311518
http://dx.doi.org/10.1186/s12882-019-1440-9
work_keys_str_mv AT chiangjuikun comparisonofmedicaloutcomesandhealthcarecostsattheendoflifebetweendialysispatientswithandwithoutcanceranationalpopulationbasedstudy
AT chenjeanshi comparisonofmedicaloutcomesandhealthcarecostsattheendoflifebetweendialysispatientswithandwithoutcanceranationalpopulationbasedstudy
AT kaoyeehsin comparisonofmedicaloutcomesandhealthcarecostsattheendoflifebetweendialysispatientswithandwithoutcanceranationalpopulationbasedstudy